Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Viemed Healthcare (VMD) Gross Margin (2018 - 2025)

Viemed Healthcare (VMD) has disclosed Gross Margin for 6 consecutive years, with 57.89% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Gross Margin fell 165.0% year-over-year to 57.89%, compared with a TTM value of 57.52% through Dec 2025, down 188.0%, and an annual FY2025 reading of 57.52%, down 188.0% over the prior year.
  • Gross Margin was 57.89% for Q4 2025 at Viemed Healthcare, up from 57.49% in the prior quarter.
  • Across five years, Gross Margin topped out at 64.33% in Q2 2021 and bottomed at 56.28% in Q1 2025.
  • Average Gross Margin over 5 years is 60.43%, with a median of 60.62% recorded in 2022.
  • The sharpest move saw Gross Margin soared 461bps in 2021, then crashed -375bps in 2024.
  • Year by year, Gross Margin stood at 61.52% in 2021, then dropped by -1bps to 61.04% in 2022, then increased by 4bps to 63.29% in 2023, then dropped by -6bps to 59.54% in 2024, then dropped by -3bps to 57.89% in 2025.
  • Business Quant data shows Gross Margin for VMD at 57.89% in Q4 2025, 57.49% in Q3 2025, and 58.25% in Q2 2025.